More young children are accidentally eating weed edibles, and Canada's pediatricians have had enough.

If it feels as if marijuana stocks can do no wrong of late, you'd be right. Since the year began, the Horizons Marijuana Life Sciences ETF, the first-ever cannabis exchange-traded fund in Canada, has risen by 60%. Although gains in February were considerably more subdued relative to January, this popular ETF still tacked on an 8% gain last month.

Among individual pot stocks, things weren't nearly as bullish in February as they were in January, when you could have seemingly thrown a dart with a blindfold on and made money. Of the 50 marijuana stocks I screened, 24 fell last month, with 26 advancing. That's a pretty even distribution.

The mayor of Kamloops, British Columbia says rules around cannabis today may be different tomorrow, after the city recently rejected two different applications for legal pot shops.

Ken Christian says there is still another shoe to drop on the legal cannabis front when edibles are legalized later this year.

He believes that will alter the dynamic and with such a new industry, he thinks there will be a natural re-evaluation of the rules.

Christian says he thinks the entire retail cannabis landscape will be reassessed once legislators have a year or two of legalization under their belts.

He says the city is probably over-served with cannabis stores right now.

One of the hottest segments in the beverage industry is the increasing popularity of seltzer waters. Among the fastest growing consumer discretionary sectors is the recreational marijuana industry. A Durango collaboration is looking to tap into the popularity of both markets.

Jonny Radding and Aaron Miles of Durango Organics have joined with Matt Vincent of Ska Brewing Co. and Ska Fabricating to produce Oh Hi Beverages, THC-infused sparkling seltzers, which should be hitting recreational marijuana dispensaries in Colorado beginning in mid-March.

A Canadian cannabis producer that has a large-scale East Ladner greenhouse among its operations has signed a clinical research deal with the National Hockey League’s Alumni Association to investigate the use of cannabinoids as a treatment for post-concussion neurological diseases in former NHL players.

In a news release this weekend, Canopy Growth, in partnership with the NHLAA and NEEKA Health Canada, says 100 former players will be enrolled in a randomized double-blind study. The research will be led by two neurosurgeons whose clinical trial may lead to novel cannabis therapies that have the potential to improve the lives of patients suffering from post-concussion healthcare issues, states Canopy.

The marijuana industry is kicking tail and taking names through the first two months of 2019. The broad-based Horizons Marijuana Life Sciences ETF is up more than 50% year to date, and pot stocks have gathered plenty of momentum following Canada's legalization of recreational weed in mid-October of last year.

When Sacha Hockenhull organized his first cannabis exposition in Calgary four years ago, his friends said he would get arrested and his family threatened to disown him.

On Saturday, he watched hundreds of people file through HempFest at the Edmonton Convention Centre, the first major event of its kind in the city since recreational marijuana legalization.

"Now the conversation is totally different," said Hockenhull. "When I say I run a cannabis show, people say, 'Tell me everything you know.'"

Alberta is leading the country in cannabis retail sales, according to Statistics Canada. The province's retailers sold nearly $33 million worth of cannabis between the Oct. 17 and Dec. 31.

How long would it take for a stock to deliver a 50% gain for you to consider it a winner? Some might say five years. Others would like a three-year big return. But what would you think about a stock that has soared over 50% in just two months and is up more than 730% in less than five years?

Aurora Cannabis (NYSE:ACB) is such a stock. Most investors would readily conclude that the Canadian marijuana grower has been a big winner. But you've no doubt heard it plenty of times: Past performance isn't necessarily indicative of future results. Is Aurora Cannabis a stock to buy now? 

When it comes to drugs, politicians agreed: Cannabis should be legalized. Mind you, for medical use. In Switzerland has passed the Motion Kessler in the previous year, the Council of States and national Council. Now the Federal Council on the train to write the law.

In Israel, has voted in February, a clear majority of the Knesset, with no votes against for the legal cultivation and Export of cannabis. The Cannabis industry has boomed prior to the recent Initiatives in both countries, partly under unclear legal conditions. Now you experienced your first High.

If you're on the hunt for a great marijuana stock to buy, remember that sometimes taking the road less traveled is the best choice. Big Canadian marijuana producers get the most attention. That makes sense in some ways because of the excitement over the Canadian recreational marijuana market. But smaller marijuana businesses that focus on the U.S. could be even smarter picks.